Medical News

RSS

Shire receives Paragraph IV Notice Letter over generic INTUNIV ANDAs from Teva Pharmaceuticals

Shire plc, announces that it has received a Paragraph IV Notice Letter from Teva Pharmaceuticals USA, Inc. advising of the filing of an Abbreviated New Drug Application for a generic version of Shire's 1 mg, 2mg, 3 mg, and 4mg guanfacine hydrochloride extended release tablets, INTUNIV(TM).

17 Mar 2010

Governors riled by lack of input in health bill; States request more federal funding for budget, Medicaid shortfalls

"Vermont Gov. Jim Douglas kicked off a National Governors Association summit on health care Monday with an ominous word about the date" and the need to beware the ides of March. "The governors feel like they've gotten the Brutus treatment, too."

17 Mar 2010

Generex Biotechnology's proprietary buccal insulin spray product presented at CODHy Congress

Generex Biotechnology Corporation (www.generex.com), the leader in drug delivery for metabolic diseases through the inner lining of the mouth, today announced that Philip Raskin, MD, of The University of Texas Southwestern Medical Center in Dallas, Texas, made a presentation in respect of Generex Oral-lyn™, the Company's proprietary buccal insulin spray product, at The Latin America Congress on Controversies to Consensus in Diabetes, Obesity and Hypertension held in Buenos Aires, Argentina, March 11-14, 2010 (www.comtecmed.com/Codhy/argentina).

17 Mar 2010

Obese patients face lower risk of sudden cardiac death compared to non-obese patients

Obesity has long been identified as a risk factor for cardiovascular disease and heart failure. But, a new study conducted by researchers at the University of Rochester Medical Center found that being skinny confers no advantage when it comes to the risk of dying suddenly from cardiac causes.

17 Mar 2010

Glenmark Generics, Konec ordered to stop marketing unapproved nitroglycerin tablets

The U.S. Food and Drug Administration today ordered Glenmark Generics of Mahwah, N.J., and Konec Inc. of Tucson, Ariz., to stop marketing unapproved nitroglycerin tablets. The tablets are placed under the tongue to relieve chest pain or to stop a heart attack and are marketed in 0.3 mg, 0.4 mg, and 0.6 mg dosages.

17 Mar 2010

Human Genome Sciences to deploy Aegis Analytical's Discoverant manufacturing intelligence solution

Aegis Analytical Corp., the leading provider of Enterprise Manufacturing Intelligence software, announced today that Human Genome Sciences, Inc. will deploy Aegis’ Discoverant® as its data management, analytics and reporting solution in the scale-up and production of BENLYSTA™ (belimumab), an investigational drug for the treatment of systemic lupus that has successfully completed Phase 3 trials.

17 Mar 2010

OVD issue highlights prevalence of eye problems in general population

In the latest issue of Optometry & Vision Development (OVD), Dr. Dominick Maino, editor of OVD, notes that: "In 2010 there are 9 million people with lazy eye and 18 million individuals with eye-turns

17 Mar 2010

Results of UBA 2010 Employer Opinion Survey Special Supplement

United Benefit Advisors, LLC, (wwwUBAbenefits.com), one of the nation's leading employee benefits advisory organizations, released the results of the UBA 2010 Employer Opinion Survey Special Supplement featuring employer opinions on future costs, plan designs and the impact of health care reform provisions being considered by both houses of Congress.

17 Mar 2010

Former GOP leader Armey predicts health bill will pass

Dick Armey, a former Republican House majority leader and one of the leaders of the Tea Party movement, said Monday "that House Speaker Nancy Pelosi is 'inept' but that Congress would likely still pass health care reform," ABC News reports. "

17 Mar 2010

Genentech submits ACTEMRA sBLA to FDA

Genentech, Inc., a wholly-owned member of the Roche Group, today announced that the company submitted a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration (FDA) for ACTEMRA® (tocilizumab) for the prevention of structural joint damage (as assessed by radiograph) and improvement in physical function in adults with moderately to severely active rheumatoid arthritis (RA).

17 Mar 2010

Heart disease patients may benefit from secondary preventive care

Research has shown that heart disease patients who make lifestyle improvements, take recommended medications and control risk factors such as high cholesterol and high blood pressure can prevent heart disease from worsening.

17 Mar 2010

Boosting radiation dose for prostate cancer patients does not increase severity of side effects

Boosting the radiation dose given to prostate cancer patients to a level that cut tumor recurrence in half did not increase the severity of side effects reported by patients up to a decade later. The study led by Massachusetts General Hospital Cancer Center researchers also found that patients characterized the impact of continuing side effects on their quality of life as considerably less bothersome than would be expected, based on earlier studies.

17 Mar 2010

Alpha II’s CodeWizard software to be integrated with MedAppz' iSuite

Alpha II, a leader in healthcare coding, compliance and reimbursement, announced today a contract with MedAppz to integrate Alpha II’s CodeWizard software with iSuite. This integration of technologies will allow iSuite users to generate evaluation and management codes (E&M), delivering a more decisive calculation based on history, exam and medical decision making information obtained from medical records.

17 Mar 2010

House Democrats move health bill with controversial, complicated strategy

House Democrats have started the clock to a landmark vote on sweeping changes to America's health care system.

17 Mar 2010

IDSA calls for global commitment to develop 10 new antibiotics by 2020

As the deaths and suffering caused by antibiotic-resistant bacterial infections continue to rise around the world, the Infectious Diseases Society of America (IDSA) is urging a global commitment to develop 10 new antibiotics by 2020, known as the 10 x '20 initiative, to address this public health crisis and safeguard patients' health.

17 Mar 2010

California jury rules insurer should pay for out-of-state operation; Mass. probe shows insurers' payments can vary widely

The Los Angeles Times: "A Los Angeles jury concluded Monday that Anthem Blue Cross should cover the cost of an out-of-state liver transplant that a California man paid for after the insurer balked. In addition, the jury ordered Blue Cross to pay plaintiff Ephram Nehme's legal expenses, which could dwarf the $206,000 cost of the transplant. Blue Cross approved Nehme's liver transplant in late 2006, and he was on the waiting list at UCLA Medical Center.

17 Mar 2010

Artefill: First and only FDA-approved microsphere-enhanced dermal filler for correction of smile lines

Getting older is a fact of life. Looking older doesn't have to be. Patients now have a non-invasive treatment option to reduce the signs of aging and fight wrinkles for good -- with no downtime. Known for their use of the latest technological advancements, Dr. Gilbert Lee and his team at Changes Plastic Surgery & Spa are now using Artefill, the first and only FDA-approved microsphere-enhanced dermal filler for the correction of smile lines, or the lines from your nose to the corners of your mouth.

17 Mar 2010

Emdeon signs definitive agreement to acquire HTMS

Emdeon Inc., a leading provider of healthcare revenue and payment cycle management solutions, today announced the signing of a definitive agreement to acquire Healthcare Technology Management Services, a management consulting company focused primarily on the healthcare payer market.

17 Mar 2010

Celerus Diagnostics to present Wave RPD totally automated HC staining system at annual USCAP meeting

Celerus Diagnostics will introduce a totally automated immunohistochemistry (IHC) staining system, the much-anticipated Wave RPD, at the United States and Canadian Association of Pathologists (USCAP) annual meeting being held in Washington DC, March 22–24. The new system is the first of its kind, capable of delivering totally automated IHC results in one hour.

17 Mar 2010

EU-India free-trade negotiations could limit access to affordable, generic drugs, advocacy group says

The advocacy group Medecins Sans Frontieres (MSF) recently warned that free-trade negotiations between the EU and India could limit access to "affordable generic drugs" for people in India and the rest of the developing world, Reuters reports.

17 Mar 2010

Medical News

Shire receives Paragraph IV Notice Letter over generic INTUNIV ANDAs from Teva Pharmaceuticals

Governors riled by lack of input in health bill; States request more federal funding for budget, Medicaid shortfalls

Generex Biotechnology's proprietary buccal insulin spray product presented at CODHy Congress

Obese patients face lower risk of sudden cardiac death compared to non-obese patients

Glenmark Generics, Konec ordered to stop marketing unapproved nitroglycerin tablets

Human Genome Sciences to deploy Aegis Analytical's Discoverant manufacturing intelligence solution

OVD issue highlights prevalence of eye problems in general population

Results of UBA 2010 Employer Opinion Survey Special Supplement

Former GOP leader Armey predicts health bill will pass

Genentech submits ACTEMRA sBLA to FDA

Heart disease patients may benefit from secondary preventive care

Boosting radiation dose for prostate cancer patients does not increase severity of side effects

Alpha II’s CodeWizard software to be integrated with MedAppz' iSuite

House Democrats move health bill with controversial, complicated strategy

IDSA calls for global commitment to develop 10 new antibiotics by 2020

California jury rules insurer should pay for out-of-state operation; Mass. probe shows insurers' payments can vary widely

Artefill: First and only FDA-approved microsphere-enhanced dermal filler for correction of smile lines

Emdeon signs definitive agreement to acquire HTMS

Celerus Diagnostics to present Wave RPD totally automated HC staining system at annual USCAP meeting

EU-India free-trade negotiations could limit access to affordable, generic drugs, advocacy group says

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Latest News